Free Trial
NASDAQ:ARAY

Accuray Q4 2025 Earnings Report

Accuray logo
$1.28 -0.03 (-2.29%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$1.27 -0.01 (-0.39%)
As of 08/1/2025 04:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Accuray EPS Results

Actual EPS
N/A
Consensus EPS
$0.03
Beat/Miss
N/A
One Year Ago EPS
N/A

Accuray Revenue Results

Actual Revenue
N/A
Expected Revenue
$123.78 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Accuray Announcement Details

Quarter
Q4 2025
Time
Before Market Opens
Conference Call Date
Wednesday, August 13, 2025
Conference Call Time
4:30PM ET

Conference Call Resources

Accuray Earnings Headlines

Ex-Hedge Fund Manager Uncovers $100 Trillion Land Shift
Trump's Radical New Plan Could Enrich Thousands This isn't a campaign stunt. It's a $100 trillion move to unlock federal lands, oil reserves, and buried minerals... all for profit. Trump's team is already executing the orders... and Wall Street legend Whitney Tilson is stepping forward to show you how to position before the deadline.
See More Accuray Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Accuray? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Accuray and other key companies, straight to your email.

About Accuray

Accuray (NASDAQ:ARAY) designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.

View Accuray Profile

More Earnings Resources from MarketBeat